BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15580150)

  • 1. An historical overview of the treatment of Crohn's disease: why do we need biological therapies?
    Rutgeerts PJ
    Rev Gastroenterol Disord; 2004; 4 Suppl 3():S3-9. PubMed ID: 15580150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: Medical therapy for fistulizing Crohn's disease.
    Bressler B; Sands BE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1283-93. PubMed ID: 17059510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perianal fistulizing Crohn's disease: a call to action.
    Kamm MA; Ng SC
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):7-10. PubMed ID: 18063415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.
    Prantera C; Berto E; Scribano ML; Falasco G
    Ital J Gastroenterol Hepatol; 1998 Dec; 30(6):602-6. PubMed ID: 10076781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: treatment of perianal fistulizing Crohn's disease.
    Rutgeerts P
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():106-10. PubMed ID: 15352905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
    Sandborn WJ; Feagan BG; Lichtenstein GR
    Aliment Pharmacol Ther; 2007 Oct; 26(7):987-1003. PubMed ID: 17877506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatment modalities in active Crohn's disease.
    Biancone L; Pallone F
    Ital J Gastroenterol Hepatol; 1999; 31(6):508-14. PubMed ID: 10575571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease.
    Rutgeerts P
    Mediators Inflamm; 1998; 7(3):137-40. PubMed ID: 9705597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
    Chebli JM; Gaburri PD; De Souza AF; Pinto AL; Chebli LA; Felga GE; Forn CG; Pimentel CF
    J Gastroenterol Hepatol; 2007 Feb; 22(2):268-74. PubMed ID: 17295882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
    Vermeire S; van Assche G; Rutgeerts P
    Aliment Pharmacol Ther; 2007 Jan; 25(1):3-12. PubMed ID: 17229216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of medically induced remission of Crohn's disease.
    Gonvers JJ; Juillerat P; Mottet C; Pittet V; Felley C; Vader JP; Michetti P; Froehlich F
    Digestion; 2007; 76(2):116-29. PubMed ID: 18239403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
    de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
    Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroids in Crohn's disease.
    Yang YX; Lichtenstein GR
    Am J Gastroenterol; 2002 Apr; 97(4):803-23. PubMed ID: 12003413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of recto-urethral fistulas in Crohn's disease].
    Aiello C; Santoro GA; Cerbone V; de Werra C; Gentile M; Bucci L
    Minerva Chir; 1997 Sep; 52(9):1129-34. PubMed ID: 9432589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing complicated Crohn's disease in children and adolescents.
    Homan M; Baldassano RN; Mamula P
    Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):572-9. PubMed ID: 16327836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.
    Frøslie KF; Jahnsen J; Moum BA; Vatn MH;
    Gastroenterology; 2007 Aug; 133(2):412-22. PubMed ID: 17681162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C; Beau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of fistulizing Crohn's disease.
    Judge TA; Lichtenstein GR
    Gastroenterol Clin North Am; 2004 Jun; 33(2):421-54, xi-xii. PubMed ID: 15177547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.